Resource-efficient pooled sequencing expands translational impact in solid tumors
Kidney Cancer Journal · 2021
DOI: 10.52733/kcj18n2.a1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Cancer Journal, 2021. Verfasst von Renzo G DiNatale und 17 weiteren Autor:innen. Beteiligte Einrichtung: Computational Oncology Service, Epidemiology & Biostatistics Department, Memorial Sloan Kettering Cancer Center, New York, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Intratumoral genetic heterogeneity (ITH) poses a significant challenge to utilizing sequencing for decision making in the management of cancer. Although sequencing of multiple tumor regions can address the pitfalls of ITH, it does so at a significant increase in cost and resource utilization. We propose a pooled multiregional sequencing strategy, whereby DNA aliquots from multiple tumor regions are mixed prior to sequencing, as a cost-effective strategy to boost translational value by addressing ITH while preserving valuable residual tissue for secondary analysis. Focusing on kidney cancer, we demonstrate that DNA pooling from as few as two regions significantly increases mutation detection while reducing clonality misattribution. This leads to an increased fraction of patients identified with therapeutically actionable mutations, improved patient risk stratification, and improved inference of evolutionary trajectories with an accuracy comparable to bona fide multiregional sequencing. The same approach applied to non-small-cell lung cancer data substantially improves tumor mutational burden (TMB) detection. Our findings demonstrate that pooled DNA sequencing strategies are a cost-effective alternative to address intrinsic genetic heterogeneity in clinical settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Computational Oncology Service, Epidemiology & Biostatistics Department, Memorial Sloan Kettering Cancer Center, New York, USA.
- Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, USA.
- Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.
- Biostatistics, Epidemiology & Biostatistics Department, Memorial Sloan Kettering Cancer Center, New York, USA.
- Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, NY.
- Department of Urology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY.
Förderung
- NCI NIH HHS
Zitieren
APA
DiNatale, R. G., Mano, R., Makarov, V., Rusk, N., Drill, E., Winer, A., Sankin, A., Yoo, A., Freeman, B. A., Hsieh, J. J., Chen, Y. B., Coleman, J. A., Berger, M., Ostrovnaya, I., Chan, T. A., Russo, P., Reznik, E., & Hakimi, A. A. (2021). Resource-efficient pooled sequencing expands translational impact in solid tumors. Kidney Cancer Journal. https://doi.org/10.52733/kcj18n2.a1
Vancouver
DiNatale RG, Mano R, Makarov V, Rusk N, Drill E, Winer A, et al. Resource-efficient pooled sequencing expands translational impact in solid tumors. Kidney Cancer Journal. 2021. doi:10.52733/kcj18n2.a1
BibTeX
@article{DiNatale2021,
author = {DiNatale, Renzo G and Mano, Roy and Makarov, Vladimir and Rusk, Nicole and Drill, Esther and Winer, Andrew and Sankin, Alexander and Yoo, Angela and Freeman, Benjamin A and Hsieh, James J and Chen, Ying-Bei and Coleman, Jonathan A and Berger, Michael and Ostrovnaya, Irina and Chan, Timothy A and Russo, Paul and Reznik, Ed and Hakimi, A Ari},
title = {Resource-efficient pooled sequencing expands translational impact in solid tumors},
journal = {Kidney Cancer Journal},
year = {2021},
doi = {10.52733/kcj18n2.a1}
}
EUVIMED